Asset Advisors Corp’s Medtronic MDT Stock Holding History

Asset Advisors Corp’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,210	Closed	-$349K	–	189
2015 Q3	$349K	Buy	5,210 +345	+7%	+$25.4K	0.09%	83
2015 Q2	$360K	Buy	4,865 +4,565	+1,522%	+$349K	0.08%	87
2015 Q1	$23K	Buy	+300	New	+$22.7K	0.01%	133

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Asset Advisors Corp's MDT Position: Q4 2015 in Review

Asset Advisors Corp sold out of Medtronic (MDT) in Q4 2015, closing a stake of 5,210 shares — an estimated $349K sold.

Asset Advisors Corp first reported a position in MDT in Q1 2015 and held it in 3 quarters. The position peaked at $360K in Q2 2015. 1,251 funds tracked by Wall St. Rank hold MDT as of Q4 2015.

Asset Advisors Corp reported no remaining Medtronic position as of Q4 2015 after selling out during the quarter.
Asset Advisors Corp sold 5,210 Medtronic shares in Q4 2015, an estimated $349K.
Asset Advisors Corp first reported a position in Medtronic in Q1 2015 and held it in 3 quarters.
Asset Advisors Corp's Medtronic position peaked at $360K in Q2 2015.
1,251 funds tracked by Wall St. Rank held Medtronic as of Q4 2015.

Based on Asset Advisors Corp's 13F filing for Q4 2015, filed 26 Jan 2016.